Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy

Bone anabolic agents promoting bone formation and rebuilding damaged bones would ideally overcome the limitations of anti‐resorptive therapy, the current standard prescription for osteoporosis. However, the currently prescribed parathyroid hormone (PTH)‐based anabolic drugs present limitations and a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:EMBO Mol Med
Autores principales: Kim, Hyun‐Yi, Choi, Sehee, Yoon, Ji‐Hye, Lim, Hwan Jung, Lee, Hyuk, Choi, Jiwon, Ro, Eun Ji, Heo, Jung‐Nyoung, Lee, Weontae, No, Kyoung Tai, Choi, Kang‐Yell
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818757/
https://ncbi.nlm.nih.gov/pubmed/26941261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201505714
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares